课题基金 / 基金详情

Serological tools for COVID-19 control and vaccine roll-out in Southeast Asia

Serological tools for COVID-19 control and vaccine roll-out in Southeast Asia
用于在东南亚控制 COVID-19 和疫苗推广的血清学工具
批准号:
MR/V036890/1
负责人:
Taane Clark
金额:
$53.08万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Taane Clark的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has caused immeasurable burden on economies and public health globally, including in Asia. New diagnostics for detecting the present and past exposure to the virus have been developed, and vaccines are emerging for clinical evaluation and roll-out. As the number of cases plateau, the exit strategy of Governments will involve the use of surveillance and contact tracing to limit the damage of future sporadic outbreaks in the short to medium term, while vaccination will ideally lead to elimination. However, many of the tests and vaccines under evaluation are based on the same biological targets, and infection control activities will need to distinguish immune responses to vaccines and those elicited by SARS-CoV-2 infection, which cannot yet be achieved with current front-line rapid testing kits. With this in mind, we propose to investigate alternative immunological targets arising from LSHTM modelling, informatic tools and laboratory work. These targets will be assessed within ongoing collaborations with government research institutes and hospitals in Thailand and The Philippines, who are at the forefront of clinical management and infection control in the COVID-19 response. These sites have pre-existing biological samples and data collected for diagnosis and treatment that will be used in the proposed project. We will evaluate new biological targets and establish assays that can be implemented by these countries to assist a surveillance system to monitor the progress of vaccination and SARS-CoV-2 elimination in the community. This will provide vital data for the direction of vaccine rollout and containment strategy. Most importantly, the tools developed can be easily implemented across other LMIC countries with a minimal laboratory set-up. With this, our goal, is to make a lasting contribution to Southeast Asian COVID-19 surveillance infrastructure, thereby improving the health and economy of the nations.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12864-022-08853-6
发表时间: 2022-09-01
期刊: BMC genomics
影响因子: 4.4
作者: []
通讯作者:
Additional file 1 of Genomic surveillance of SARS-COV-2 reveals diverse circulating variant lineages in Nairobi and Kiambu Counties, Kenya
SARS-COV-2 基因组监测的附加文件 1 揭示了肯尼亚内罗毕县和基安布县的多种流行变异谱系
DOI: 10.6084/m9.figshare.20787040
发表时间: 2022
期刊:
影响因子: --
作者: [Kuja J]
通讯作者: Kuja J
AI assisted genomic profiling for the personalisation of treatment and control of infections
Using whole genome sequencing to reveal malaria parasite genetic diversity and drug resistance in Vietnam
A lung-oriented controlled human infection model using live BCG to evaluate tuberculosis immunopathogenicity and vaccine efficacy (TB-CHIM).
Using host-responses and pathogen genomics to improve diagnostics for tuberculosis in Bandung, Indonesia
海外基金